Brain Case completed tens of millions of yuan in angel round financing time:.
Its viral vector tools can serve the fields of brain science, cell gene therapy, and oncolytic viruses. On August 20, 2022, Brain Case(Shenzhen) Biotechnology Co., Ltd. (hereinafter referred to as Blinkers) announced the completion of tens of millions
2023-11-06
